Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pipsa Saharinen

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
The Journal of Clinical Investigation|August 23, 2016
Opposing actions of angiopoietin-2 on Tie2 signaling and FOXO1 activationMinah Kim, Breanna Allen, Emilia A Korhonen, et al.
Nature Cell Biology|April 22, 2008
Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contactsPipsa Saharinen, Lauri Eklund, Juho Miettinen, et al.
Molecular Cancer Therapeutics|July 20, 2019
Receptor Tyrosine Kinase Signaling Networks Define Sensitivity to ERBB Inhibition and Stratify <i>Kras</i>-Mutant Lung CancersSarang S Talwelkar, Ashwini S Nagaraj, Jennifer R Devlin, et al.
Physiological Genomics|January 20, 2007
Transcriptomal comparison of human dermal lymphatic endothelial cells ex vivo and in vitroNikolaus Wick, Pipsa Saharinen, Juha Saharinen, et al.
JCI Insight|November 16, 2023
DLL4/Notch3/WNT5B axis mediates bidirectional prometastatic crosstalk between melanoma and lymphatic endothelial cellsSanni Alve, Silvia Gramolelli, Joonas Jukonen, et al.
The Journal of Clinical Investigation|October 2, 2014
VEGF-C and aortic cardiomyocytes guide coronary artery stem developmentHeidi I Chen, Aruna Poduri, Harri Numi, et al.
Circulation Research|April 24, 2024
Contribution of VEGF-B-Induced Endocardial Endothelial Cell Lineage in Physiological Versus Pathological Cardiac HypertrophyIbrahim Sultan, Markus Ramste, Pim Peletier, et al.
The Journal of Clinical Investigation|January 17, 2014
Tie1 deletion inhibits tumor growth and improves angiopoietin antagonist therapyGabriela D'Amico, Emilia A Korhonen, Andrey Anisimov, et al.
Journal of the National Cancer Institute|February 21, 2012
Effects of angiopoietin-2-blocking antibody on endothelial cell-cell junctions and lung metastasisTanja Holopainen, Pipsa Saharinen, Gabriela D'Amico, et al.
The Journal of Clinical Investigation|June 15, 2026
Inactive β1-integrin acts as a junctional scaffold for angiopoietin/TIE2/FOXO1 signalingTuomas Sipilä, Srinivas Kumar Ponna, Abhinandan Venkatesha Murthy, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
The Journal of Clinical Investigation|August 23, 2016
Opposing actions of angiopoietin-2 on Tie2 signaling and FOXO1 activationMinah Kim, Breanna Allen, Emilia A Korhonen, et al.
Nature Cell Biology|April 22, 2008
Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contactsPipsa Saharinen, Lauri Eklund, Juho Miettinen, et al.
Molecular Cancer Therapeutics|July 20, 2019
Receptor Tyrosine Kinase Signaling Networks Define Sensitivity to ERBB Inhibition and Stratify <i>Kras</i>-Mutant Lung CancersSarang S Talwelkar, Ashwini S Nagaraj, Jennifer R Devlin, et al.
Physiological Genomics|January 20, 2007
Transcriptomal comparison of human dermal lymphatic endothelial cells ex vivo and in vitroNikolaus Wick, Pipsa Saharinen, Juha Saharinen, et al.
JCI Insight|November 16, 2023
DLL4/Notch3/WNT5B axis mediates bidirectional prometastatic crosstalk between melanoma and lymphatic endothelial cellsSanni Alve, Silvia Gramolelli, Joonas Jukonen, et al.
The Journal of Clinical Investigation|October 2, 2014
VEGF-C and aortic cardiomyocytes guide coronary artery stem developmentHeidi I Chen, Aruna Poduri, Harri Numi, et al.
Circulation Research|April 24, 2024
Contribution of VEGF-B-Induced Endocardial Endothelial Cell Lineage in Physiological Versus Pathological Cardiac HypertrophyIbrahim Sultan, Markus Ramste, Pim Peletier, et al.
The Journal of Clinical Investigation|January 17, 2014
Tie1 deletion inhibits tumor growth and improves angiopoietin antagonist therapyGabriela D'Amico, Emilia A Korhonen, Andrey Anisimov, et al.
Journal of the National Cancer Institute|February 21, 2012
Effects of angiopoietin-2-blocking antibody on endothelial cell-cell junctions and lung metastasisTanja Holopainen, Pipsa Saharinen, Gabriela D'Amico, et al.
The Journal of Clinical Investigation|June 15, 2026
Inactive β1-integrin acts as a junctional scaffold for angiopoietin/TIE2/FOXO1 signalingTuomas Sipilä, Srinivas Kumar Ponna, Abhinandan Venkatesha Murthy, et al.
Pageof 6